ROCKLAND, Mass.--(BUSINESS WIRE)--July 13, 2006--BioSphere Medical, Inc. (Nasdaq:BSMD - News), the medical device company that pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a procedure called embolization, announced today that it will hold its quarterly conference call to discuss second quarter 2006 results on July 27, 2006, at 11:00 a.m. Eastern Time (10 a.m. Central Time).
